Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Children and Adolescents With Primary B-precursor Acute Lymphoblastic Leukemia With Combination Chemotherapy and Immunotherapy

NCT04723342 is registered in ClinicalTrials.gov with Federal Research Institute of Pediatric Hematology, Oncology and Immunology as lead sponsor.

NCT NCT04723342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Children and Adolescents With Primary B-precursor Acute Lymphoblastic Leukemia With Combination Chemotherapy and Immunotherapy
Lead sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2020
Completion date
December 31, 2025
Enrollment
180 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute lymphoblastic leukemia